Corporate Announcement
Security Code : 507789    Company : JAGSNPHARM    
 
Outcome of AGM 
  Exchange Disseminated Time     
Jagsonpal Pharmaceuticals Ltd has informed BSE that the members at the 32nd Annual General Meeting (AGM) of the Company held on September 30, 2011, inter alia, have transacted the following:

1. Adopted the Audited Balance Sheet as at March 31, 2011 and the Profit and loss account for the Year ended on that date along with the reports of the Auditors’ and Directors’ thereon.

2. Declared 10% dividend on the 2,61,98,000 Equity Shares of Rs. 5/- each.

3. Re-appointed Dr. S. K. Goyal as Director whose period of office is liable to determination by retirement of Directors by rotation.

4. Appointed M/s. P. P. Thukral & Company, Chartered Accountants as Auditor to hold office till the conclusion of next Annual General Meeting.

5 Approved Appointment and remunerations of Mr. Rajpal Singh Kochhar as Managing Director, Whole Time Director.

6. Approved Appointment and remunerations of Mr. Mr. Prithipal Singh Kochhar as Managing as Vice President - International Business.
 

Disclaimer

Back To Announcements